An independently innovative pharmaceutical research and development enterprise
Quality stems from design, achieved through execution, and reaches perfection.
ABOUT US
Company Introduction
Founded on November 12, 2013, Nanjing Kangchuanji Pharmatech Co., Ltd. is located at No.199 Wenfang Road, Jiangning District, Nanjing, Jiangsu Province, China. In late 2021, Zhejiang Jiuzhou Pharmaceutical Co., Ltd. completed a capital increase in our company, acquiring a 51% controlling stake.
We operate a 5,700 m² R&D center, fully equipped with comprehensive R&D facilities and standardized management systems.
Our core technical team is led by senior professors from China Pharmaceutical University, bringing over 30 years of hands-on drug development experience. We also engage external experts from CPU specializing in pharmaceutics and pharmaceutical analysis to collaborate on solving complex technical challenges. We employ over 120 R&D professionals, most of whom hold PhD, master’s or bachelor’s degrees in pharmacy-related fields. They graduated from top domestic pharmaceutical universities including China Pharmaceutical University, Shenyang Pharmaceutical University and Nanjing University of Chinese Medicine, with solid professional technical backgrounds.
Our business scope covers:
· R&D of innovative drugs, modified new drugs and high-end generic drugs
· Quality and Efficacy Consistency Evaluation for Generic Drugs
· Technical consulting
· Drug registration application
· Marketing Authorization Holder (MAH) services
30+ Years of Industry Experience
120+ R&D Professionals
5,700+ ㎡ R&D Center
30+ Years of Drug Development Experience
50+ Core Technology Products
Innovation and R&D
Innovation and R&D
Our business scope covers: R&D of innovative drugs, modified new drugs and high-end generic drugs · Quality and Efficacy Consistency Evaluation for Generic Drugs · Technical consulting · Drug registration application · Marketing Authorization Holder (MAH) services
PRODUCTS
Products
Our business covers high-difficulty sustained-release and controlled-release preparations, generic drug development based on patent challenges, consistency evaluation of oral and injectable preparations, CMC for innovative drugs/improved new drugs/generic drugs, regulatory filing, and MAH (Marketing Authorization Holder). We have comprehensive, full-lifecycle, process-oriented R&D and technical service capabilities — from early formulation design evaluation and preclinical studies to pilot-scale production, commercial manufacturing, and regulatory submission.
Pharmaceutical Research Services
Our company has an pharmaceutical R&D team with full experience in sustained-release and controlled-release preparations, solubility enhancement of poorly soluble drugs, topical preparations, orally disintegrating preparations, soft capsules, liquid preparations, and eye drops. We provide generic drug API and preparations development as well as innovative drug preparations development, including pre-formulation studies, formulation screening, process development, quality studies, stability studies, and other pharmaceutical research services and technical support. We also assist in selecting suppliers of APIs, excipients, and packaging materials, developing and upgrading internal control standards for materials, supporting API/preparations companies to upgrade and maintain the manufacturing and quality management system, and helping them to complete process validation.
Consistency Evaluation Services
Passing the generic drug consistency evaluation or being listed in the Chinese Approved Drug Products Directory is an essential requirement for companies to participate in tender and centralized procurement. If a generic drug becomes the "first" or "among the top three" to pass the evaluation, it brings significant market and economic benefits. Otherwise, there is a high risk of losing market share or even the drug approval.
Our company has a professional team specializing in pharmaceutical R&D, regulatory registration, and quality management. With extensive project experience, we can provide professional analysis, advice, and solutions to clients on pharmaceutical research and registration-related issues — such as project initiation investigation, RLD selection, quality studies, drug registration filing, and generic drug consistency evaluation. We offer the following technical consulting services:
In 2017, China introduced the "Marketing Authorization Holder (MAH)" system for drugs, opening a door for R&D institutions and researchers to own their own drugs. At the same time, it also requires them to assume a series of corresponding legal responsibilities — covering the entire drug lifecycle: from R&D, supply chain management, manufacturing (with contract manufacturers), distribution and sales, adverse reaction monitoring, product lifecycle management, to product registration changes and renewals.
Technological Achievements Transference
Our company has completed early-stage research on multiple products, which are now ready for technological transference and further development. Welcome companies interested in cooperation to contact us.
NEWS
News
07
/
03
2026-07-03
News
06
/
29
2026-06-29
News
03
/
23
2026-03-23
News
A Strong Start to the New Year – Kangchuanji Achieves Multiple Approvals
Please contact us for more detailed information.
Kangchuanji Pharmatech looks forward to working with you and jointly creating a bright future!
Follow us
Nanjing Kangchuanji Pharmatech Co., Ltd.
Contact Us：18020149597（HR）
Recruitment Email:recruit@kcjpharma.com
Address: 2nd Floor, Building 5, No.199 Wenfang Road, Jiangning District, Nanjing, Jiangsu Province, China（Jiangning High-tech Park）
Copyright © Nanjing Kangchuanji Pharmatech Co., Ltd.